BioWorld

Oct. 29, 2003

View Archived Issues

Genentech, Xoma's Raptiva Receives Psoriasis Approval

Genentech Inc. and partner XOMA Ltd. won FDA approval for Raptiva, a biologic for psoriasis that can be self-administered once weekly on a continuous basis. (BioWorld Today) Read More

Avonex Boosts Biogen Again; Psoriasis Drug Proves Weaker

Read More

Novel Strategies To Expand Blood Stem Cells In Mice Look Likely In People, Too; Clinical Trials Impend

Read More

Avera In-Licenses From Novartis Anxiety, Depression Compound

Read More

Other News To Note

Read More